Prediction of tumor spread through air spaces with an automatic segmentation deep learning model in peripheral stage I lung adenocarcinoma
- PMID: 40057743
- PMCID: PMC11890504
- DOI: 10.1186/s12931-025-03174-0
Prediction of tumor spread through air spaces with an automatic segmentation deep learning model in peripheral stage I lung adenocarcinoma
Abstract
Background: To evaluate the clinical applicability of deep learning (DL) models based on automatic segmentation in preoperatively predicting tumor spread through air spaces (STAS) in peripheral stage I lung adenocarcinoma (LUAD).
Methods: This retrospective study analyzed data from patients who underwent surgical treatment for lung tumors from January 2022 to December 2023. An external validation set was introduced to assess the model's generalizability. The study utilized conventional radiomic features and DL models for comparison. ROI segmentation was performed using the VNet architecture, and DL models were developed with transfer learning and optimization techniques. We assessed the diagnostic accuracy of our models via calibration curves, decision curve analysis, and ROC curves.
Results: The DL model based on automatic segmentation achieved an AUC of 0.880 (95% CI 0.780-0.979), outperforming the conventional radiomics model with an AUC of 0.833 (95% CI 0.707-0.960). The DL model demonstrated superior performance in both internal validation and external testing cohorts. Calibration curves, decision curve analysis, and ROC curves confirmed the enhanced diagnostic accuracy and clinical utility of the DL approach.
Conclusion: The DL model based on automatic segmentation technology shows significant promise in preoperatively predicting STAS in peripheral stage I LUAD, surpassing traditional radiomics models in diagnostic accuracy and clinical applicability. Clinical trial number The clinical trial was registered on April 22, 2024, with the registration number researchregistry10213 ( www.researchregistry.com ).
Keywords: Deep Learning; Lung Adenocarcinoma; Radiomics; Tumor Spread through Air Spaces.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013), The ethics committee of Xuzhou Cancer Hospital approved the study protocol (2023–02-027-K01); This work was supported by the Natural Science Foundation of China (No.82001987); This work was supported by the Key Project of Yancheng Municipal Health Commission (YK2023007). Consent for publication: Not applicable. Competing interests: The authors declare that they have no conflict of interest. Informed consent: Due to the retrospective nature of our study, informed consent from patients was waived.
Figures
References
-
- Travis WD, Brambilla E, Nicholson AG, et al. WHO panel. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10(9):1243–60. - PubMed
-
- Ren Y, Xie H, Dai C, et al. Prognostic impact of tumor spread through air spaces in sublobar resection for 1A lung adenocarcinoma patients. Ann Surg Oncol. 2019;26:1901–8. - PubMed
-
- Suzuki K, Saji H, Aokage K, et al. Comparison of pulmonary segmentectomy and lobectomy: safety results of a randomized trial. J Thorac Cardiovasc Surg. 2019;158(3):895–907. - PubMed
-
- Chen D, Mao Y, Wen J, et al. Tumor spread through air spaces in non-small cell lung cancer: a systematic review and meta-analysis. Ann Thorac Surg. 2019;108(3):945–54. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
